On Wednesday, in a significant development drugmaker Pfizer Inc said, all of its patented medicines including COVID-19 treatment Paxlovid and big-selling breast cancer drug Ibrance will be made available at not-for-profit prices to 45 of the world’s poorest countries. The bouquet… Read More ›
Paxlovid
Pfizer’s surge in revenue triggers potential acquisitions
On Tuesday, investors hope to learn Pfizer Inc’s plans for what could be a once in a generation cash infusion from COVID-19 treatments and vaccines in 2022. Some drugmakers are looking to spend on potential acquisitions. According to Chief Executive Albert… Read More ›